By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Center for Stem Cell and Regenerative Medicine 

10900 Euclid Avenue
Wolstein Research Building 2-501

Case Western Reserve University Campus
Cleveland  Ohio  44106  U.S.A.
Phone: 216-368-1017 Fax: 216-368-6020



Arteriocyte  (CSCRM startup company) is an early-stage company developing proprietary stem cell based therapies to grow new blood vessels for patients with a variety of vascular diseases.

Athersys  is a Founding member of CSCRM and is actively developing therapeutics based on the Multipotent Adult Progenitor Cell (MAPC) technology, originally developed by Dr. Catherine Verfaillie and colleagues at the University of Minnesota and licensed exclusively to Athersys. The company has numerous collaborations with CSCRM investigators and institutions to rapidly advance its product candidates to the clinic.

Cell Targeting  (CSCRM startup company) addresses the fundamental problems of cellular therapy: the quantity and location of stem cells.

Cleveland Clinic  is one of the world's largest and busiest health centers and is a Founding member of CSCRM. Patients come to The Cleveland Clinic from all over the world for advanced treatment in all illnesses and disorders of the body. In cardiology and cardiac surgery, they lead the nation as evidenced by the Heart Center’s number one rank in America for eleven years in row in U.S. News.

RegenRx  (CSCRM startup company) capitalizes on the induction of homing in stem cells to areas of myocardial injury by specific factors.

Company News
Athersys, Inc. and Center for Stem Cell and Regenerative Medicine Receive Grant Funding to Support Research Into Novel Stem Cell Treatment of Spinal Cord Injury 6/25/2010 11:37:13 AM
Case Western Reserve University School of Medicine, Cleveland Clinic And Area Companies Team To Create Ohio Center For Neural Repair 10/26/2006 11:15:37 AM
Rogue Proteins Found In Unexpected Organs10/19/2005 5:12:31 PM
Researchers Discover New Gene In Colon Cancer: A Naturally Occurring COX-2 Inhibitor10/19/2005 5:12:31 PM
GELITA Health Initiative: New Clinical And Experimental Data Confirm The Importance Of Collagen Hydrolysate In The Treatment Of Degenerative Joint Disease 10/19/2005 5:12:21 PM
Federal Funding Provided To Case Western Reserve University, Cleveland Clinic And University Hospitals For Non-Embryonic Stem Cell Research10/19/2005 5:12:17 PM
New Oral Vaccine For Alzheimer's Disease10/19/2005 5:11:57 PM
Review Of Peregrine Pharmaceuticals's (PPHM) Phase I Cotara(R) Clinical Data For Colorectal Cancer To Be Presented At Cancer Therapy Meeting 10/19/2005 5:11:54 PM
Study Identifies Target For Preventing Sexual Transmission Of HIV10/19/2005 5:11:52 PM
Findings Redefine Mechanism Of Action Of RNA Helicase Enzymes10/19/2005 5:11:14 PM